Blastomycosis North American - Symptoms & Treatment
Blastomycosis is a chronic systemic mycosis characterized by main pulmonary infection, which in some cases is followed by hematogenous diffusion to skin and other organs. The fungus is endemic to countries in Central America, North and South America, most especially Brazil, Argentina, Colombia, and Venezuela, in regions confidential as subtropical mountain forests. Infection with P brasiliensis is usually sub clinical; however, the fungus occasionally proliferates, causing severe illness. An infectious fungal disease that begins in the lungs. It can infrequently spread through the bloodstream to other body parts, particularly the skin.
Blastomycosis may causes meningitis, cerebral abscesses, pericarditis, and arthritis. Blastomycosis is found in North America (where Blastomyces dermatitidis commonly inhabits the soil). The incubation period ranges from weeks to months. Untreated blastomycosis is gradually progressive and usually deadly, though spontaneous remission may occur. The mortality rate is 15% in suitably treated cases.
Causes and risk factor of Blastomycosis North American
People who have diabetes mellitus other who are taking drugs that stifle the immune system (immunocompromised) are more likely to grow blastomycosis. Although people with AIDS can get blastomycosis because of their weakened immune system, blastomycosis has not been one of the more ordinary fungal infections related with AIDS. Some causes & risk factors of Blastomycosis North American are as follows:
- More contact to the soil is the most important factor to cause this disease.
- It is mostly occur to the people with HIV and organ transplant recipients.
- Direct inoculation is responsible to cause cutaneous blastomycosis.
Symptoms of Blastomycosis North American
Some sign and symptoms related to Blastomycosis North American are as follows:
- Shortness of breath.
- Weight loss.
- Joint stiffness.
- Chest pain.
Treatment of Blastomycosis North American
Treatment for all forms of blastomycosis has conventionally been intravenous amphotericin B (Fungi zone). While amphotericin B is still the treatment of option for severe infections other infections in immunocompromised hosts, oral ketoconazole (Nizoral) has lately been used successfully for less severe infections. Ketoconazole may be given in a dosage of 400 to 800 mg per day for up to six months.
- Blastomycosis must be treated other it will slowly lead to death.
- A diet having food of less sugar, honey and fruit juice, products of vitamin-C, E, A+ and B complex and also raw and unprocessed food products, can play a very significant role in treating the blastomycosis.
- Alternative treatment for fungal infections focuses on creating an interior atmosphere where the fungus may not survive. Ketoconazole other fluconazole may be used as a choice. Patient care is mainly supportive.